Liu et al. suggested that MCM6 could indicate poor prognosis and promote migration and invasion, which could be predicted preclinical early recurrence in HCC patients to indicate more careful monitoring and aggressive treatment intervention [14]. The gene discussed is MCM6; the disease is hepatocellular carcinoma.